...
  • 主题
高级搜索  >
历史搜索 清空历史
首页> 外文期刊>Dermatologic surgery >Treatment of poikiloderma of Civatte using intense pulsed light source: 7 years of experience.
【24h】

Treatment of poikiloderma of Civatte using intense pulsed light source: 7 years of experience.

机译：使用强脉冲光源治疗Civatte的鬼臼皮病：7年的经验。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       
页面导航
  • 摘要
  • 著录项
  • 相似文献
  • 相关主题

摘要

BACKGROUND AND OBJECTIVE: The treatment of choice of poikiloderma of Civatte should address both pigmented and vascular lesions at the same time. A broad-spectrum, noncoherent intense pulsed light (IPL) source can be used to obtain this effect. In this study, we investigated the clinical efficacy and side effects of treating this condition with IPL. MATERIALS AND METHODS: A total of 175 patients with poikiloderma of Civatte of the neck and chest were treated with IPL at various settings. The mean age of patients of various skin types (Fitzpatrick I to III) was 49 years. They were subjected to a treatment protocol including three sessions every 3 weeks. At follow-up visit, performed 3 months after the last treatment, clinical improvement was evaluated for all patients by comparing pre- and posttreatment photographs. The patients also scored their overall satisfaction. RESULTS: Clearance of more than 80% of vascular and pigmented components of poikiloderma of Civatte was observed. Minimal and transient side effects occurred in 5% of the patients. No scarring or pigment disturbances were noted after the treatments. CONCLUSIONS: The IPL source can be considered a safe and effective therapeutic option for poikiloderma of Civatte, allowing a marked improvement of vascular and pigmented lesions with minimal side effects.
机译：背景与目的：选择西瓦特（Civatte）的古朴皮的方法应同时针对色素性病变和血管性病变。可以使用广谱非相干强脉冲光（IPL）源来获得此效果。在这项研究中，我们调查了IPL治疗该病的临床疗效和副作用。材料与方法：共175例颈部和胸部Civatte皮肤性单核皮病患者接受了IPL不同设置的治疗。各种皮肤类型（费兹帕特里克一世至三世）患者的平均年龄为49岁。他们接受了包括每3周3次疗程的治疗方案。在最后一次治疗后3个月进行的随访中，通过比较治疗前后的照片评估了所有患者的临床改善情况。患者还对他们的总体满意度进行了评分。结果：观察到了超过80％的Civatte的鬼臼皮病的血管和色素成分的清除。 5％的患者发生了最小和短暂的副作用。治疗后未发现疤痕或色素紊乱。结论：IPL来源可被认为是Civatte的鬼臼皮病的一种安全有效的治疗选择，可显着改善血管和色素性病变，且副作用最小。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

  • 客服微信

  • 服务号